These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2133042)

  • 1. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome.
    Kish SJ; Kleinert R; Minauf M; Gilbert J; Walter GF; Slimovitch C; Maurer E; Rezvani Y; Myers R; Hornykiewicz O
    Am J Psychiatry; 1990 Oct; 147(10):1358-63. PubMed ID: 2133042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue.
    Spokes EG
    Brain; 1979 Jun; 102(2):333-46. PubMed ID: 455043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical analysis of transmitters in the brains of multiple system atrophy].
    Kwak S
    No To Shinkei; 1985 Jul; 37(7):691-4. PubMed ID: 2415143
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in catecholamine levels in discrete regions of rat brain during aging.
    Roubein IF; Embree LJ; Jackson DW
    Exp Aging Res; 1986; 12(4):193-6. PubMed ID: 3569394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain neurotransmitter abnormalities in neuronal intranuclear inclusion body disorder.
    Kish SJ; Gilbert JJ; Chang LJ; Mirchandani L; Shannak K; Hornykiewicz O
    Ann Neurol; 1985 Apr; 17(4):405-7. PubMed ID: 2408557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Concentration of monoamines in the brain of minks differing in their reaction to man].
    Nikulina EM; Trapezov OV; Popova NK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(6):1142-6. PubMed ID: 2418599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of norepinephrine and dopamine in mouse brain regions following microwave inactivation--rapid post-mortem degradation of striatal dopamine in decapitated animals.
    Blank CL; Sasa S; Isernhagen R; Meyerson LR; Wassil D; Wong P; Modak AT; Stavinoha WB
    J Neurochem; 1979 Jul; 33(1):213-9. PubMed ID: 37287
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.
    Sparks DL; Hunsaker JC; Slevin JT; DeKosky ST; Kryscio RJ; Markesbery WR
    Ann Neurol; 1992 Jun; 31(6):611-20. PubMed ID: 1355334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain neurotransmitters in dystonia musculorum deformans.
    Hornykiewicz O; Kish SJ; Becker LE; Farley I; Shannak K
    N Engl J Med; 1986 Aug; 315(6):347-53. PubMed ID: 2426591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioenzymatic assay for the simultaneous measurement of noradrenaline, dopamine and their non-O-methylated metabolites.
    Bardsley M; Bachelard HS
    Cell Mol Biol Incl Cyto Enzymol; 1981; 27(2-3):71-6. PubMed ID: 7296612
    [No Abstract]   [Full Text] [Related]  

  • 11. No evidence for lateral asymmetry of neurotransmitters in post-mortem human brain.
    Rossor M; Garrett N; Iversen L
    J Neurochem; 1980 Sep; 35(3):743-5. PubMed ID: 6108998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin.
    Kish SJ; Kalasinsky KS; Furukawa Y; Guttman M; Ang L; Li L; Adams V; Reiber G; Anthony RA; Anderson W; Smialek J; DiStefano L
    Mol Psychiatry; 1999 Jan; 4(1):26-32. PubMed ID: 10089005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
    Ruberg M; Javoy-Agid F; Hirsch E; Scatton B; LHeureux R; Hauw JJ; Duyckaerts C; Gray F; Morel-Maroger A; Rascol A
    Ann Neurol; 1985 Nov; 18(5):523-9. PubMed ID: 3000280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of dopamine and noradrenaline in the brains of three patients with Parkinson's disease who died in the course of treatment with L-dopa].
    Buscaino GA; Sori A; Campanella G
    Rev Neurol (Paris); 1972 Aug; 127(2):301-2. PubMed ID: 4666634
    [No Abstract]   [Full Text] [Related]  

  • 17. [Abnormalities of neurotransmitters in Alzheimer's disease. Disturbance of the acetylcholine system and nucleus basalis of Meynert].
    Arai H; Iizuka R
    Nihon Rinsho; 1988 Jul; 46(7):1491-5. PubMed ID: 3221455
    [No Abstract]   [Full Text] [Related]  

  • 18. Lateral asymmetry of neurotransmitters in human brain.
    Glick SD; Ross DA; Hough LB
    Brain Res; 1982 Feb; 234(1):53-63. PubMed ID: 6120746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low melanin content of substantia nigra in a case of neuroleptic malignant syndrome.
    Gertz HJ; Schmidt LG
    Pharmacopsychiatry; 1991 May; 24(3):93-5. PubMed ID: 1891487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
    Kish SJ; Chang LJ; Mirchandani L; Shannak K; Hornykiewicz O
    Ann Neurol; 1985 Nov; 18(5):530-6. PubMed ID: 2416269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.